Iatrogenic dermatitis.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000498:Allyl Compounds / Q000009:adverse effects; D001284:Atrophy; D001566:Benzocaine / Q000009:adverse effects; D001585:Benzoyl Peroxide / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D005029:Ethylenediamines / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D007093:Imidazoles / Q000009:adverse effects; D007809:Lanolin / Q000009:adverse effects; D008709:Methenamine / Q000009:adverse effects / Q000031:analogs & derivatives; D009355:Neomycin / Q000009:adverse effects; D010226:Parabens / Q000009:adverse effects; D010636:Phenols / Q000009:adverse effects; D011409:Propylene Glycols / Q000009:adverse effects; D012393:Rosacea / Q000139:chemically induced; D012867:Skin / Q000473:pathology; D014508:Urea / Q000009:adverse effects / Q000031:analogs & derivatives; D014992:Xylenes / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000498:Allyl Compounds; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D010226:Parabens; D010636:Phenols; D011409:Propylene Glycols; D014992:Xylenes; C007027:chloroxylenol; D007809:Lanolin; D014508:Urea; C018375:quaternium-15; D009355:Neomycin; D008709:Methenamine; C006048:imidazolidinyl urea; D001566:Benzocaine; D001585:Benzoyl Peroxide